Effect of nanomolar concentrations of sodium dodecyl sulfate, a catalytic inductor of α-helices, on human calcitonin incorporation and channel formation in planar lipid membranes

Biophysical Journal

Volumn 87, Issue 2, 2004, Pages 1065-1075

  Micelli, Silvia ^a   Meleleo, Daniela ^a   Picciarelli, Vittorio ^a   Stoico, Maria G ^a   Gallucci, Enrico ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; DODECYL SULFATE SODIUM; NANOPARTICLE; PEPTIDE HORMONE;

ALPHA HELIX; ARTICLE; BETA SHEET; CALCIUM METABOLISM; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; HYDROPHOBICITY; LIPID MEMBRANE; MOLECULAR INTERACTION; PEPTIDE ANALYSIS; PHOSPHATE METABOLISM; PROTEIN FOLDING; PROTEIN STABILITY;

EID: 4143073487     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.103.037200     Document Type: Article

References (84)

1. Altland, K., and P. Winter. 2003. Polyacrylamide gel electrophoresis followed by sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis for the study of the dimmer to monomer transition of human transthyretin. Electrophoresis. 24:2265-2271.
2. Amodeo, P., A. Motta, G. Strazzullo, and M. A. Castiglione Morelli. 1999. Conformational flexibility in calcitonin: The dynamic properties of human and salmon calcitonin in solution. Journal Biomol. NMR. 13: 161-174.
3. Arvinte, T., A. Cudd, and A. F. Drake. 1993. The structure and mechanism of formation of human calcitonin fibrils. J. Biol. Chem. 268:6415-6422.
4. Auluck, P. K., H. Y. Chan, J. Q. Trojanowski, V. M. Lee, and N. M. Bonini. 2002. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 295:865-868.
5. Barrow, C. J., and M. G. Zagorski. 1991. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science. 253:180-182.
6. Bauer, H. H., M. Muller, J. Goette, H. P. Merkle, and U. P. Fringeli. 1994. Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR Spectroscopy. Biochemistry. 33:12276-12282.
7. Benz, R., K. Janko, W. Boos, and P. Läuger. 1978. Formation of large, ion-permeable channels by the matrix protein (porin) of Escherichia coli. Biophys. J. 511:305-319.
8. Bloom, M., E. Evans, and O. G. Mouritsen. 1991. Physical properties of the fluid lipid-bilayer component of cell membranes: a perspective. Q. Rev. Biophys. 24:293-397.
9. Bradshaw, J. P. 1997. Phosphatydylglicerol promotes bilayer insertion of salmon calcitonin. Biophys. J. 72:2180-2186.
10. Coles, M., W. Bicknell, A. A. Watson, D. P. Fairlie, and D. J. Craik. 1998. Solution structure of amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:11064-11077.
11. Doi, M., Y. Kobayashi, Y. Kyogoku, M. Takimoto, and K. Goda. 1990. Structure study of human calcitonin. In Peptides: Chemistry, Structure and Biology. Eleventh American Peptide Symposium. J. E. Rivier and R. Marshall, editors. ESCOM, Leiden, The Netherlands. 165-167.
12. Engelman, D. M., and T. A. Steitz. 1981. The spontaneous insertion of proteins into and across membranes: the helical hairpin hypothesis. Cell. 23:411-422.
13. Epand, R. M., R. F. Epand, R. C. Orlowski, R. J. Schlueter, L. T. Boni, and S. W. Hui. 1983. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids. Biochemistry. 22:5074-5084.
14. Fisher, J. A., P. H. Tobler, M. Kaufmann, W. Bom, H. Henke, P. E. Cooper, S. M. Sagar, and J. B. Martin. 1981. Calcitonin: Regional distribution of the hormone and its binding sites in the human brain and pituitary. Proc. Natl. Acad. Sci. USA. 778:7801-7805.
15. Gallucci, E., D. Meleleo, S. Micelli, and V. Picciarelli. 2003. Magainin 2 channel formation in PLMs: the role of polar lipid groups and ergosterol. Eur. Biophys. J. 32:22-32.
16. Gallucci, E., S. Micelli, and G. Monticelli. 1996. Pore formation in lipid bilayer membranes made of phosphatidylinositol and oxidized cholesterol followed by means of alternating current. Biophys. J. 71:824-831.
17. Galvin, J. E., K. Uryu, V. M. Lee, and J. C. Trojanowski. 1999. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta- and gamma-synuclein. Proc. Natl. Acad. Sci. USA. 96:13450-13455.
18. Gray, C., S. A. Tatulian, S. A. Wharton, and L. K. Tamm. 1996. Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophys. J. 70:2275-2286.
19. Harper, J. D., and P. T. Lansbury Jr. 1997. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:385-407.
20. Jacobs, R. E., and S. H. White. 1989. The nature of the hydrophobic binding of small peptides at the bilayer interface: implications for the insertion of transbilayer helices. Biochemistry. 28:3421-3437.
21. Ji, S. R., Y. Wu, and S. F. Sui. 2002. Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (Aβ1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277: 6273-6279.
22. Jordi, W., B. De Kruijff, and D. Marsh. 1989. Specificity of the interaction of amino- and carboxy-terminal fragments of the mitochondrial precursor protein apocytochrome c with negatively charged phospholipids. A spin-label electron spin resonance study. Biochemistry. 28:8998-9005.
23. +-ATPase: Enzyme sources, preparative problems, and preparation from mammalian kidney. In Methods in Enzymology, 156. S. Fleischer and B. Fleischer, editors. Academic Press, San Diego, CA. 29-43.
24. 13C NMR. Protein Sci. 9:867-877.
25. Kanaori, K., and A. Y. Nasaka. 1995. Study of human calcitonin fibrillation by proton nuclear magnetic resonance spectroscopy. Biochemistry. 34:12138-12143.
26. Keller, R. C. A., J. A. Killian, and B. de Kruijff. 1992. Anionic phospholipids are essential for the α-helix formation of the signal peptide of prePhoE upon interaction with phospholipids vesicles. Biochemistry. 31:1672-1677.
27. Killian, J. A., I. Salemink, M. R. R. de Planque, G. Lindblom, R. E. Koeppe 2nd, and D. V. Greathouse. 1996. Induction of nonbilayer structures in diacylphosphatidylcholine model membranes by transmembrane α-helical peptides: importance of hydrophobic mismatch and proposed role of tryptophans. Biochemistry. 35:1037-1045.
28. Kliger, Y., A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y. Shai. 1997. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study. J. Biol. Chem. 272:13496-13505.
29. Kohno, T., K. Kobayashi, T. Maeda, K. Sato, and A. Takashima. 1996. Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment. Biochemistry. 35:16094-16104.
30. Kragh-Hansen, U., M. le Maire, and J. V. Møller. 1998. The Mechanism of detergent, solubilization of liposomes and protein-containing membranes. Biophys. J. 75:2932-2946.
31. Kremer, J. J., M. M. Pallitto, D. J. Sklansky, and R. M. Murphy. 2000. Correlation of β-amyloid size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry. 39:10309-10318.
32. Lee, C. M., and H. I. Maibach. 1995. The sodium lauryl sulfate model: an overview. Contact Dermatitis. 33:1-7.
33. Martinez-Senac, M., S. Gorbalan-Garcia, and J. C. Gomez-Fernandez. 2002. The structure of the C-terminal domain of the pro-apoptotic protein Bak and its interaction with model membranes. Biophys. J. 82:233-243.
34. McLaurin, J., and A. Chakrabartty. 1996. Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids and gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271:26482-26489.
35. McLaurin, J., D. S. Yang, C. M. Yip, and P. E. Fraser. 2000. Review: Modulating factors in amyloid-β fibril formation. J. Struct. Biol. 130:259-270.
36. Micelli, S., E. Gallucci, and V. Picciarelli. 2000. Studies of mitochondrial porin incorporation parameters and voltage-gated mechanisms with different black lipid membranes. Bioelectrochemistry. 52:63-75.
37. Micelli, S., D. Meleleo, V. Picciarelli, and E. Gallucci. 2004. Effect of sterols on β-amyloid peptide (AβP 1-40) channel formation and their properties in PLMs. Biophys. J. 86:2231-2237.
38. Milik, M., and J. Skolmick. 1993. Insertion of peptide chains into lipid membranes: an off-lattice Monte Carlo dynamics model. Proteins. 15:10-25.
39. Montserret, R., M. McLeich, A. Bockmann, C. Geourjon, and F. Penin. 2000. Involvement of electrostatic interaction in the mechanism of peptide folding induced by sodium dodecyl sulfate binding. Biochemistry. 39:8362-8373.
40. Motta, A., A. Pastore, N. A. Goud, and M. A. Castiglione Morelli. 1991. Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations. Biochemistry. 30:10444-10450.
41. Motta, A., G. Andreotti, P. Amodeo, G. Strazullo, and M. A. Castiglione Morelli. 1998. Solution structure of human calcitonin in membrane-mimetic environment: The role of the amphipathic helix. Proteins. 32:314-323.
42. Mouritsen, O. G., and M. Bloom. 1984. Mattress model of lipid-protein interactions in membranes. Biophys. J. 46:141-153.
43. Muga, A., W. Neugebauer, T. Hirama, and W. K. Surewicz. 1994. Membrane interaction and conformational properties of the putative fusion peptide of PH-30, a protein active in sperm-egg fusion. Biochemistry. 33:444-448.
44. Mueller, P., and D. O. Rudin. 1968. Action potential induced in biomolecular lipid membranes. Nature. 217:713-719.
45. Nettleton, E. J., P. Tito, M. Sunde, M. Bouchard, C. M. Dobson, and C. V. Robinson. 2000. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79:53-65.
46. Niidome, T., R. Kawakami, K. Okamoto, N. Ohmori, H. Mihara, and H. Aoyagi. 1997. Interaction of lipophilic peptides derived from mastoparan with phospholipid vesicles. J. Pept. Res. 50:8-64.
47. Papavoine, C. H., R. N. Konings, C. W. Hilbers, and F. J. van de Ven. 1994. Location of M13 coat protein in sodium dodecyl sulfate micelles as determined by NMR. Biochemistry. 33:12990-12997.
48. Pereira, F. B., F. M. Goni, A. Muga, and J. L. Nieva. 1997. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV -1 fusion peptide adopting an extended conformation: dose and sequence effects. Biophys. J. 73:1977-1986.
49. 1H heteronuclear NMR spectroscopy. Eur. J. Biochem. 219: 571-583.
50. Popp, B., A. Schmid, and R. Benz. 1996. Role of stertols in the functional reconstitution of water-soluble mitochondrial porins from different organisms. Biochemistry. 34:3352-3361.
51. Prusiner, S. B., D. F. Groth, D. C. Bolton, S. B. Kent, and L. E. Hood. 1984. Purification and structural studies of a major scrapie prion protein. Cell. 38:127-134.
52. Quina, F. H., P. M. Nassar, J. B. S. Bonilha, and B. L. Bales. 1995. Growth of sodium dodecyl sulfate micelles with detergent concentration. J. Phys. Chem. 99:17028-17031.
53. Rafalski, M., A. Ortiz, A. Rockwell, L. C. van Ginkel, J. D. Lear, W. F. DeGrado, and J. Wilschut. 1991. Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles. Biochemistry. 30:10211-10220.
54. Rapaport, D., and Y. Shai. 1994. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes. J. Biol. Chem. 269:5124-5131.
55. Reches, M., Y. Porat, and E. Gazit. 2002. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J. Biol. Chem. 38:35475-35480.
56. Reynolds, J. A., and C. Tanford. 1970. The gross conformation of protein-sodium dodecyl sulfate complexes. J. Biol. Chem. 245:5161-5165.
57. Rinia, H. A., R. A. Kik, R. A. Demel, M. M. E. Snel, J. A. Killian, J. P. J. M. van der Eerden, and B. de Kruijff. 2000. Visualization of highly ordered domains induced by transmembrane peptides in supported phosphatidylcholine bilayers. Biochemistry. 39:5852-5858.
58. Rizzo, A. J., and D. Goltzman. 1981. Calcitonin receptors in the central nervous system of the rat. Endocrinology. 108:1672-1677.
59. Rymer, D. L., and T. A. Good. 2001. The role of G protein activation in the toxicity of amyloidogenic Aβ-(1-40), Aβ-(25-35), and bovine calcitonin. J. Biol. Chem. 26:2523-2530.
60. Sargent, D. F., J. W. Bean, and R. Schwyzer. 1988. Conformation and orientation of regulatory peptides on lipid membranes. Key to the molecular mechanism of receptor selection. Biophys. Chem. 31:183-193.
61. Schubert, D., C. Behl, R. Lesley, A. Breck, R. Dargush, Y. Sagara, and H. Kimura. 1995. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92:1989-1993.
62. Segre, G. V., and S. R. Goldring. 1993. Receptors for secretin, calcitonin, parathyroid hormone (PTH/PTH related peptide), vasoactive intestinal peptide, glucagone-like peptide 1, growth hormone-releasing hormone, and glucagone belong to a newly discovered G-protein receptor family. Trends Endocrinol. Metab. 4:309-314.
63. Sexton, P. M., D. M. Findlay, and T. J. Martin. 1999. Calcitonin. Curr. Med. Chem. 6:1067-1093.
64. Shimura, H., M. G. Schlossmacher, N. Hattori, M. P. Frosch, A. Trockenbacher, R. Schneider, Y. Mizuno, K. S. Kosik, and D. J. Selkoe. 2001. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science. 293:263-269.
65. Singer, M. M., and R. S. Tjeerdema. 1993. Fate and effects of the surfactant sodium dodecyl sulfate. Rev. Environ. Contam. Toxicol. 133:95-149.
66. Sirisattha, S., Y. Momose, E. Kitagawa, and H. Iwahashi. 2004. Toxicity of anionic detergents determined by Saccharomyces cerevisiae microarray analysis. Water Research. 38:61-70.
67. Sletten, K., P. Westermark, and J. B. Natwig. 1976. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J. Exp. Med. 143:993-998.
68. Sticht, H., P. Bayer, P. Willbold, D. Dames, S. Hilbich, C. Beyreuther, K. W. Frank, and P. Rosch. 1995. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 233:16094-16104.
69. Stipani, V., E. Gallucci, S. Micelli, V. Picciarelli, and R. Benz. 2001. Channel formation by salmon and human calcitonin in black lipid membranes. Biophys. J. 8:3332-3338.
70. Tan, A., A. Ziegler, B. Steinbauer, and J. Seelig. 2002. Thermodynamics of sodium dodecyl sulfate partitioning into lipid membranes. Biophys. J. 83:1547-1556.
71. Terzi, E., G. Holzemann, and J. Seelig. 1994. Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry. 33:7434-7441.
72. Terzi, E., G. Holzemann, and J. Seelig. 1995. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252:633-642.
73. Terzi, E., G. Holzemann, and J. Seelig. 1997. Interaction of Alzheimer β-Amyloid peptide(1-40) with lipid membranes. Biochemistry. 36: 14845-14852.
74. Thomas, P. J., Y. H. Ko, and P. L. Pedersen. 1992. Altered protein folding may be the molecular basis of most cases of cystic fibrosis. FEBS Lett. 312:7-9.
75. Tjernberg, L., W. Hosia, N. Bark, J. Thyberg, and J. Johansson. 2002. Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J. Biol. Chem. 277:43243-43246.
76. Wallach, S., G. Rousseau, L. Martin, and M. Azria. 1999. Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone. 25:509-516.
77. White, S. H., and W. C. Wimley. 1999. Membrane protein folding and stability: physical principles. Annu. Rev. Biophys. Biomol. Struct. 28:319-365.
78. Wieprecht, T., M. Beyermann, and J. Seelig. 1999. Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure. Biochemistry. 38:10377-10387.
79. Wu, C. S. C., and J. T. Yang. 1978. Conformation of naturally-occurring peptides in surfactant solution: its relation to the structure-forming potential of amino acid sequence. Biochem. Biophys. Res. Commun. 82:85-91.
80. Yang, D. S., C. M. Yip, T. H. J. Huang, A. Chakrabartty, and P. E. Fraser. 1999. Manipulating the amyloid-β aggregation pathway with chemical chaperones. J. Biol. Chem. 274:32970-32974.
81. Yip, C. M., A. A. Darable, and J. McLaurin. 2002. Aβ42-peptide assembly on lipid bilayers. J. Mol. Biol. 318:97-107.
82. Yip, C. M., and J. McLaurin. 2001. Amyloid-β peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 80: 1359-1371.
83. Yonath, A., A. Podjamy, B. Honig, A. Sielecki, and W. Traub. 1977. Crystallographic studies of protein denaturation and renaturation. 2. Sodium dodecyl sulfate induced structural changes in triclinic lysozyme. Biochemistry. 16:1418-1424.
84. 1H NMR of a prototypic alpha-helical peptide (LYQELQKLTQTLK) and homologs in trifluoroethanol/water and on sodium dodecyl sulfate micelles. J. Pept. Res. 50:122-131.